REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2026
In 2026, REVIVA PHARMACEUTICALS HOLDINGS, INC.'s disclosed short interest ran from 20.49% of shares outstanding on 15 Jan 2026 to 14.57% on 30 Apr 2026, a change of -5.92 percentage points. The year's high was 20.58% on 30 Jan 2026 and its low 11.16% on 15 Apr 2026, averaging 16.80% across 7 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.03 days on 13 Feb 2026. Full history: REVIVA PHARMACEUTICALS HOLDINGS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 20.49% (15 Jan 2026)
- End of year
- 14.57% (30 Apr 2026)
- Change
- -5.92 pp
- High
- 20.58% (30 Jan 2026)
- Low
- 11.16% (15 Apr 2026)
- Average
- 16.80%
- Highest days to cover
- 10.03 (13 Feb 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 20.49% | 4.85 | |
| 30 Jan 2026 | 20.58% | 7.68 | |
| 13 Feb 2026 | 19.19% | 10.03 | |
| 27 Feb 2026 | 17.27% | 6.18 | |
| 31 Mar 2026 | 14.32% | 1.28 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 11.16% | 1.95 | |
| 30 Apr 2026 | 14.57% | 4.90 |
See also: REVIVA PHARMACEUTICALS HOLDINGS, INC.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.